On May 20, 2022, MiMedx Group Inc announced that independent proxy advisory firm Glass Lewis & Co recommended its shareholders to vote for all its board nominees and Company's Say-on-Pay Proposal at the annual meeting of shareholders scheduled to be held on June 7, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.275 USD | +0.48% | -0.08% | -28.34% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.34% | 922M | |
-20.60% | 129M | |
-9.39% | 61.39M | |
+6.64% | 60.85M | |
+14.87% | 60.15M | |
+0.60% | 51.57M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Glass Lewis & Co Supports MiMedx Group Inc Nominees and Proposals